← FDA Drug Approvals (Drugs@FDA)

ISTURISA

NDA · New Drug Application · Sponsor: RECORDATI RARE · Approved 2020-03-06

Drug application

FDA Application #

NDA212801

Application type

New Drug Application

Brand name

ISTURISA

Generic name

OSILODROSTAT

Active ingredients

OSILODROSTAT PHOSPHATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

RECORDATI RARE

Manufacturer

Recordati Rare Diseases, Inc.

First approval

2020-03-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown